Shares of Intec Pharma Ltd (NASDAQ:NTEC) were down 2.5% on Thursday . The stock traded as low as $5.52 and last traded at $5.52, with a volume of 100,849 shares trading hands. The stock had previously closed at $5.66.

Separately, Zacks Investment Research lowered shares of Intec Pharma from a “hold” rating to a “sell” rating in a research report on Tuesday, April 26th.

The stock’s market capitalization is $65.48 million. The stock’s 50-day moving average is $4.70 and its 200 day moving average is $4.15.

Intec Pharma Ltd is an Israel-based drug development company. It is a development stage biopharmaceutical company that develops formulations of drugs using its proprietary gastric retention technology, the Accordion Pill. The Accordion Pill, a novel gastro-retentive delivery system, improves the pharmacokinetics and pharmacodynamics of various drugs.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.